Peritumoral FOXP3+ regulatory T cell is sensitive to chemotherapy while intratumoral FOXP3+ regulatory T cell is prognostic predictor of breast cancer patients

Author： Liu Fangfang   Li Yaqing   Ren Meijing   Zhang Xinmin   Guo Xiaojing   Lang Ronggang   Gu Feng   Fu Li  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.135, Iss.2, 2012-09, pp. : 459-467

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cyclooxygenase-2 genetic variants influence intratumoral infiltration of Foxp3-positive regulatory T cells in non-small cell lung cancer

By  

Oncology Reports, Vol. 33, Iss. 1, 2015-01 ,pp. : 74-80

Spandidos Publications

Access to resources Recommend Favorite

Clinical significance of expanded Foxp3+ Helios- regulatory T cells in patients with non-small cell lung cancer

By                            

International Journal of Oncology, Vol. 47, Iss. 6, 2015-01 ,pp. : 2082-2090

Spandidos Publications

Access to resources Recommend Favorite

Peripheral Foxp3+ regulatory T cells and natural killer group 2, member D expression levels in natural killer cells of patients with colorectal cancer

By                      

Molecular Medicine Reports, Vol. 10, Iss. 2, 2014-01 ,pp. : 977-982

Spandidos Publications

Access to resources Recommend Favorite

Predictive and prognostic factors in locally advanced breast cancer: effect of intratumoral FOXP3+ Tregs

By Demir Lutfiye   Yigit Seyran   Ellidokuz Hulya   Erten Cigdem   Somali Isil   Kucukzeybek Yuksel   Alacacioglu Ahmet   Cokmert Suna   Can Alper   Akyol Murat   Dirican Ahmet   Bayoglu Vedat   Sari Aysegul   Tarhan Mustafa  

Clinical and Experimental Metastasis, Vol. 30, Iss. 8, 2013-12 ,pp. : 1047-1062

Springer Publishing Company

Access to resources Recommend Favorite

Tumor suppressor and T-regulatory functions of Foxp3 are mediated through separate signaling pathways

By                

Oncology Letters, Vol. 2, Iss. 4, 2011-01 ,pp. : 665-668

Spandidos Publications

Access to resources Recommend Favorite